Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

In addition to Auvelity and Sunosi, our two FDA approved treatments for major depressive disorder and excessive daytime sleepiness and narcolepsy start to sleep apnea respectively, our pipeline ...

Left untreated, OSA is linked to daytime sleepiness and an increased risk of anxiety, diabetes, hypertension and stroke. For ...

Mandibular advancement devices, which look a bit like a gumshield, help to hold your airway open and are effective at ...

Dr. Saha continued, “In addition to ORX750, we are advancing a growing pipeline of OX2R agonists targeting excessive daytime ...

ShareA new study has suggested that seniors who are drowsy during the day and find it hard to muster enthusiasm for ...

A new study has found that poor sleep quality may increase the risk of developing motoric cognitive risk syndrome (MCR), a ...

Harmony Biosciences surpassed $2 billion in cumulative net product revenue less than 5 years on the market, highlighting ...

Sleep apnea is a condition that many people mistake or ignore, even though it stands to have serious repercussions on the ...

Among participants who experienced excessive daytime sleepiness and a lack of enthusiasm, 35.5% developed motoric cognitive ...

Your brain might be behind that afternoon slump—it could be more than just a case of the sleepies. Scientists have discovered ...

Based on their findings, the researchers suggest a potential need for screening for coexisting sleep disorder symptoms in ...